A statistic by StrategyHelix indicates that the in vitro diagnostics (IVD) market in China is anticipated to expand positively at a CAGR of 15.6% during the forecast period (2021-2027).
This 2nd edition of In vitro diagnostics (IVD) Market in China includes following information:
Market Overview: Market Size, Grow Rate, CAGR
Application: Immunology, Biochemical Diagnostics, Molecular Diagnostics, Point of Care Testing (POCT), Microbiological Diagnostics, Blood Diagnostics, Others
Competitors: Roche Holding AG, Abbott Laboratories, Danaher Corporation, Siemens AG, Sysmex Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Autobio Diagnostics Co., Ltd., Others
Years Considered: this database covers the period 2014-2027
After you have placed your order and your payment has been authorized, the database download link will be emailed to you instantly. Please note that the database is supplied in an Excel spreadsheet.
StrategyHelix’ data is protected by copyright and cannot be supplied to any third party.
StrategyHelix DataPass produces a series of directories and databases on industries, economies and consumers in Western and Central Europe, North and South America, Asia Pacific, the Middle East and Africa. DataPass aims at helping our clients analyze market context and identify future trends.